Table 1 Demographic and clinical characteristics of study participants.
Characteristic | N = 91 |
|---|---|
Demographics: | |
Age, median (range) yrs. | 26 (2–87) |
Female, n (%) | 45 (49.45) |
Nationality, n (%) | |
Uganda | 88 (96.7) |
Rwanda | 2 (2.2) |
Other | 1 (1.1) |
Region of birth, n (%) | |
Central | 40 (44.4) |
Eastern | 13 (14.4) |
Western | 25 (27.8) |
Northern | 11 (12.2) |
Not in Uganda | 1 (1.1) |
Clinical Characteristics: | |
Primary Diagnosis, n (%) | |
Acute lymphocytic leukemia | 30 (33.0) |
Acute myeloid leukemia | 16 (17.6) |
Chronic myeloid leukemia | 3 (3.3) |
Chronic lymphocytic leukemia | 6 (6.6) |
Hodgkin lymphoma | 5 (5.5) |
Non-Hodgkin lymphoma | 20 (22.0) |
Multiple myeloma | 9 (9.9) |
Myelodysplastic syndrome | 1 (1.1) |
Other | 1 (1.1) |
HIV Status, n (%): | |
Negative | 63 (69.2) |
Positive | 3 (3.3) |
Unknown | 25 (27.5) |
Medication (current or past), n (%): | |
Chemotherapy | 63 (70) |
Nonsteroidal anti-inflammatory drugs (NSAIDs) | 16 (18.2) |
Laboratory studies, median (range) | |
Hemoglobin (g/dL) | 7.9 (4.1–13.9) |
Platelets (×109/L) | 63.3 (3.9–611) |
WBC (×109/L) | 6.3 (0.47–426) |
